BridgeMD
Tests treatment safety and results for Sepsis
Official title Efficacy and Safety of Electroacupuncture for ICU Sepsis Patients
ClinicalTrials.gov ID: NCT06666946
What this study is testing
- What it's testing
- The purpose of this study is to evaluate the efficacy and safety of electroacupuncture (EA) combined with standard Intensive Care Unit (ICU) therapy on organ dysfunction and other clinical outcomes in sepsis patients. Additionally, this study will conduct subgroup analyses to investigate the influence of septic shock and immunomodulators on the treatment effects and their correlation with electroacupuncture efficacy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 1\. Age ≥ 18 years old, and gender is not limited.
- 2\. Meets the diagnostic criteria of Sepsis (Sepsis-3): In patients with infection or suspected infection, Sepsis is diagnosed when the Sequential...
- 3\. Patients or their legal representatives understand and voluntarily sign the informed consent for this study.
You likely can't join if
- 1\. Patients with lower extremity denervation.
- 2\. Patients with lower extremity amputation or congenital disability with lower limb hypoplasia.
- 3\. Patients with severe acute trauma such as active bleeding or unfixed fractures in the lower extremities.
- 4\. Patients with skin damage, infection, bleeding, or hematoma near the lower extremity acupuncture site.
- 5\. Patients with implantable medical devices, such as pacemakers, implantable cardioverter defibrillators (ICD) or deep brain stimulation (DBS).
- 6\. Patients who are pregnant, breast feeding during the study.
See the full eligibility criteria
- 1\. Age ≥ 18 years old, and gender is not limited.
- 2\. Meets the diagnostic criteria of Sepsis (Sepsis-3): In patients with infection or suspected infection, Sepsis is diagnosed when the Sequential (Sepsis related) Organ Failure Assessment (SOFA) score increased by ≥2...
- 3\. Patients or their legal representatives understand and voluntarily sign the informed consent for this study.
- 1\. Patients with lower extremity denervation.
- 2\. Patients with lower extremity amputation or congenital disability with lower limb hypoplasia.
- 3\. Patients with severe acute trauma such as active bleeding or unfixed fractures in the lower extremities.
- 4\. Patients with skin damage, infection, bleeding, or hematoma near the lower extremity acupuncture site.
- 5\. Patients with implantable medical devices, such as pacemakers, implantable cardioverter defibrillators (ICD) or deep brain stimulation (DBS).
- 6\. Patients who are pregnant, breast feeding during the study.
- 7\. Patients whose expected duration of ICU length of stay is less than 48 hours.
- 8\. Patients whose legal representatives refuse routine active treatment and sign palliative treatment consent.
- 9\. Patients who are currently participating in another assigned by chance clinical trial.
- 10\. Patients or their legal representatives refused to participate in the study or were unable to sign informed consent.
- 11\. Immunosuppressive status, including but not limited to: congenital immunosuppressive patients, AIDS patients, organ transplant patients, long-term use of immunosuppressive patients, patients receiving tumor...
- 12\. Patients with an anticipated survival prognosis of no more than 7 days due to advanced disease.
The study team makes the final eligibility decision.
Where it's taking place
- Wuhan, Hubei, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.